About us   Contacts   Links   Information in Russian 
Research programms
Publications

The list of publications in 2016


1. Ionova T. I. Quality of life and symptoms in patients with myelofibrosis during the treatment: Data of clinical practice / T.I. Ionova,L.V. Anchukova, O.Yu.Vinogradova, T.A.Gritsenko,A.V. Evseev, L.K. Kozlova,K.A. Kurbatova,G.B. Kuchma,E.G. Lomaia, A.S.Lyamkina, E.R. Machulaytene,A.A. Myasnikov,T.P. Nikitina, M.M.Pankrashkina, T.I.Pospelova, A.Yu. Rodionova,E.I. Usacheva // Hematology and Transfusiology. 2016. Vol. 1: 1725. (In Russian)

2. Ionova T. I. Pharmacoeconomic analysis of use the oral hypoglycemic agents in patients with type 2 diabetes mellitus according to a real clinical practice / T.I. Ionova, T.P. Nikitina, A.Yu. Rodionova, K.A. Kurbatova // Good Clinical Practice. 2016. Vol. 1: 4146. (In Russian)

3. Ionova T. I. Practical value of the using of CSP Leuk-CML questionnaire for symptom assessment in patients with CML in a real-world setting / T.I. Ionova, O.Yu. Vinogradova, T.A. Gritsenko, T.P. Nikitina, N.V. Novitskaya, E.G. Lomaia, G.B. Kuchma, L.K. Kozlova, E.R. Machulaytene, E.I. Usacheva // Bulletin of the Multinational Center of Quality of Life Research. 2016. Vol. 27-28: 7174. (In Russian)

4. Kurbatova K.A. Application of Generalized Estimating Equations in quality of life studies in medicine / K.A. Kurbatova, T.I. Ionova // Bulletin of the Multinational Center of Quality of Life Research. 2016. Vol. 27-28: 7577. (In Russian)

5. Ionova T. I. Characteristics of psychometric properties of the CSP-Myelofibrosis Module Questionnaire for Symptom Assessment in Patients with Myelofibrosis / T.I. Ionova, T.P. Nikitina, A.Yu. Rodionova, K.A. Kurbatova // Bulletin of the Multinational Center of Quality of Life Research. 2016. Vol. 27-28: 6170. (In Russian)

6. Ionova T. I. Quality of life and health utility index in patients with type 2 diabetes mellitus receiving oral hypoglycemic therapy / T.I. Ionova, T.P. Nikitina, A.Yu. Rodionova, K.A. Kurbatova // Bulletin of the Multinational Center of Quality of Life Research. 2016. Vol. 27-28: 2127. (In Russian)

7. Salek S. Patient-Centered Research And Practice In The Era Of Genomics: A Novel Approach / S. Salek, E. Oliva, T. Ionova // Haematologica. 2016; 101 (July): 792-793. Doi:10.3324/haematol.2016.142844

8. Ionova T. Quality of Life and Symptom Burden in Myelofibrosis Patients: A Real World Study / T. Ionova, L. Anchukova, O. Vinogradova, T. Gritsenko, A. Evseev, L. Kozlova, K. Kurbatova, G. Kuchma, E. Lomaia, A. Lyamkina, E. Machulaytene, A. Myasnikov, T. Nikitina, M. Pankrashkina, T. Pospelova, A. Rodionova, E. Usacheva // Haematologica. 2016; Vol. 101 (Suppl 1): 810.

9. Salek S. The impact of hematological malignancy onpatients' health-related quality of life and symptoms: A qualitative study / S. Salek, P. Goswami, R. Else, E. Oliva, T. Ionova // Haematologica. 2016; Vol. 101 (Suppl. 1): 598.

10. Ionova T. Treatment adherence in patients with diabetes mellitus receiving oral combination therapy: data of a real-world study / T. Ionova, T. Nikitina, K. Kurbatova, A. Rodionova // Quality of Life Research. 2016; 25 (Suppl. 1): 131.

11. Ionova T. Applicability of the new instrument for symptom assessment in patients with myelofibrosis: real-world data / T. Ionova, K. Kurbatova, T. Nikitina, A. Rodionova // Quality of Life Research. 2016; 25 (Suppl. 1): 74-75.

12. Nikitina T.P. Potential prognostic value of quality of life in patients with chronic myeloid leukemia / T.P. Nikitina, T.I. Ionova, T.A. Gritsenko, L.K. Kozlova, K.A. Kurbatova, G.B. Kuchma, E.G. Lomaia, E.R. Machulaytene, N.V. Novitskaya, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva // Quality of Life Research. 2016; 25 (Suppl. 1): 120.

13. Ionova T. Quality of life indicators and symptoms in patients with chronic myelogenous leukemia in the chronic phase (CP CML) with first and second dasatinib therapy in real clinical practice / T.I. Ionova, N.B. Bulieva, O.Y. Vinogradova, T.A. Gritsenko, .. L.K. Kozlova, K.A. Kurbatova, G.B. Kuchma, E.G. Lomaia, E.R. Machulaytene, T.P. Nikitina, . N.V. Novitskaya, A.Y. Rodionova, E.I. Usacheva, T.V. Shnaider // EAFO. Clinical Hematology. 2016. Vol. 9 (3): 348. (In Russian)

14. Salek S.M. Quality of life issues relevant for patients with malignant blood diseases / S.M. Salek, E.N. Oliva, T.I. Ionova // EAFO. Clinical Hematology. 2016. Vol. 9 (3): 361. (In Russian)

15. Ionova T.I. Quality of life and symptoms in patients with myelofibrosis during the treatment: Data of clinical practice / T.I. Ionova,L.V. Anchukova, O.Yu.Vinogradova, T.A.Gritsenko,A.V. Evseev, L.K. Kozlova,K.A. Kurbatova,G.B. Kuchma,E.G. Lomaia, A.S.Lyamkina, E.R. Machulaytene,A.A. Myasnikov,T.P. Nikitina, M.M.Pankrashkina, T.I.Pospelova, A.Yu. Rodionova,E.I. Usacheva // Hematology and Transfusiology. 2016; 61 (1, suppl. 1): 122. (In Russian)

16. Ionova T.I. The use of dasatinib as the first line of therapy in patients in the chronic phase of chronic myelogenous leukemia (CML CML): clinical data and quality of life of patients in conditions of actual clinical practice / T.I. Ionova, N.B.Bulieva, K.A. Kurbatova, E.G. Lomaia, T.P. Nikitina, N.V. Novitskaya, A.Yu. Rodionova, E.I. Usacheva, M.M. Chukavina, M.V. Schumkova // Hematology and Transfusiology. 2016; 61 (1, suppl. 1): 122. (In Russian)

17. Ionova T. Quality of Life (QOL) and Health Utility (UT) in Patients with Type 2 Diabetes Mellitus (DM2) Receiving Different Oral Hypoglycemic / T. Ionova, T. Nikitina, A. Rodionova, K. Kurbatova // Therapy in a Real-World Setting. Value in Health. 2016; Volume 19 (Issue 7): A678









©

(last update): 02-10-2023